Autosomal Recessive Ataxia Due to PEX10 Deficiency
Neurology
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Autosomal Recessive Ataxia Due to PEX10 Deficiency?
There are 1 clinical trial targeting Autosomal Recessive Ataxia Due to PEX10 Deficiency tracked by BioSniper.
What is the prevalence of Autosomal Recessive Ataxia Due to PEX10 Deficiency?
The estimated prevalence of Autosomal Recessive Ataxia Due to PEX10 Deficiency is approximately 0.1 per 100,000 population.
Deep-dive into Autosomal Recessive Ataxia Due to PEX10 Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis